Gao Y, Li M M, Yu H B, Xu G Q, Xu B G, Wu M, Wang N, Liang Y C, Wang Y L, Han Yaling
Department of Cardiology, General Hospital of Northern Theater Command, Shenyang 110016, China.
The Graduate School, Dalian Medical University, Dalian 116044, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Jun 24;50(6):543-548. doi: 10.3760/cma.j.cn112148-20220403-00238.
To evaluate the success rate of His-Purkinje system pacing (HPSP) in patients with various sites of atrioventricular block (AVB) and provide clinical evidence for the selection of HPSP in patients with AVB. This is a retrospective case analysis. 637 patients with AVB who underwent permanent cardiac pacemaker implantation and requiring high proportion of ventricular pacing from March 2016 to September 2021 in the Department of Cardiology, General Hospital of Northern Theater Command were enrolled. The site of AVB was determined by electrophysiological examination. His bundle pacing (HBP) was performed in the first 130 patients (20.4%) who were classified as the HBP group and HPSP included HBP and/or left bundle branch pacing (LBBP) was performed in later 507 patients (79.6%) and these patients were classified as the HPSP group. The basic clinical information such as age and sex of the two groups was compared, and the success rates of HBP or HPSP in patients with different sites of AVB and QRS intervals were analyzed. The age of HBP group was (66.4±15.9) years with 75 males (57.7%). The age of HPSP group was (66.8±13.6) years with 288 (56.8%) males. Among 637 patients, 63.0% (401/637) had atrioventricular node block; 22.9% (146/637) had intra-His block; 14.1% (90/637) had distal or inferior His bundle block. Totally, the success rate of HPSP was higher than that of HBP [93.9% (476/507) vs. 86.9% (113/130), <0.05]. In each group of patients with various AVB sites, the success rate of HPSP was higher than that of HBP respectively and both success rates of HBP and HPSP showed a declining trend with the distant AVB site. The success rate of HBP in patients with atrioventricular node block and intra-His block was higher than that in patients with distal or inferior His bundle block [95.2% (79/83) vs. 47.1% (8/17), <0.001; 86.7% (26/30) vs. 47.1% (8/17), =0.010]. The success rate of HPSP was higher than that of HBP in patients with distal or inferior His bundle block [87.7% (64/73) vs 47.1% (8/17), =0.001]. In patients with QRS<120 ms, 94.9% (520/548) of AVB sites were in atrioventricular node or intra-His, and HBP had a similar high success rate with HPSP [95.6% (109/114) vs. 96.3% (418/434), =0.943] in these patients. In patients with QRS ≥ 120 ms, 69.7% (62/89) of AVB sites were at distal or inferior His bundle, and the success rate of HBP was only 25.0% (4/16), while the success rate of HPSP was as high as 79.5% (58/73), <0.001. In patients with QRS<120 ms and atrioventricular node block or intra-His block, success rates of HBP and HPSP are similarly high and HBP might be considered as the first choice. In patients with QRS ≥ 120 ms and AVB site at distal or inferior His bundle, the success rate of HPSP is higher than that of HBP, suggesting LBBP should be considered as the first-line treatment option.
评估希氏 - 浦肯野系统起搏(HPSP)在不同部位房室传导阻滞(AVB)患者中的成功率,并为AVB患者选择HPSP提供临床依据。这是一项回顾性病例分析。纳入2016年3月至2021年9月在北部战区总医院心内科接受永久性心脏起搏器植入且需要高比例心室起搏的637例AVB患者。通过电生理检查确定AVB部位。前130例患者(20.4%)进行希氏束起搏(HBP),归为HBP组;后507例患者(79.6%)进行HPSP(包括HBP和/或左束支起搏[LBBP]),归为HPSP组。比较两组患者的年龄、性别等基本临床信息,分析不同AVB部位和QRS间期患者的HBP或HPSP成功率。HBP组年龄为(66.4±15.9)岁,男性75例(57.7%)。HPSP组年龄为(66.8±13.6)岁,男性288例(56.8%)。637例患者中,63.0%(401/637)为房室结阻滞;22.9%(146/637)为希氏束内阻滞;14.1%(90/637)为希氏束远端或低位阻滞。总体而言,HPSP成功率高于HBP[93.9%(476/507)对86.9%(113/130),<0.05]。在不同AVB部位的每组患者中,HPSP成功率均分别高于HBP,且HBP和HPSP成功率均随AVB部位距离增加呈下降趋势。房室结阻滞和希氏束内阻滞患者的HBP成功率高于希氏束远端或低位阻滞患者[95.2%(79/83)对47.1%(8/17),<0.001;86.7%(26/30)对47.1%(8/17),=0.010]。希氏束远端或低位阻滞患者中,HPSP成功率高于HBP[87.7%(64/73)对47.1%(8/17),=0.001]。QRS<120 ms的患者中,94.9%(520/548)的AVB部位在房室结或希氏束内,这些患者中HBP与HPSP成功率相近[95.6%(109/114)对96.3%(418/434),=0.943]。QRS≥120 ms的患者中,69.7%(62/89)的AVB部位在希氏束远端或低位,HBP成功率仅为25.0%(4/16),而HPSP成功率高达79.5%(58/73),<0.001。QRS<120 ms且为房室结阻滞或希氏束内阻滞的患者,HBP和HPSP成功率均较高,HBP可作为首选。QRS≥120 ms且AVB部位在希氏束远端或低位的患者,HPSP成功率高于HBP,提示LBBP应作为一线治疗选择。